SG Americas Securities’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-22,226
| Closed | -$4K | – | 3235 |
|
|
2022
Q4 | $4K | Hold |
22,226
| – | – | ﹤0.01% | 2678 |
|
|
2022
Q3 | $10K | Buy |
22,226
+79
| +0.4% | +$36 | ﹤0.01% | 2761 |
|
|
2022
Q2 | $19K | Sell |
22,147
-6,739
| -23% | -$5.78K | ﹤0.01% | 3012 |
|
|
2022
Q1 | $159K | Sell |
28,886
-1,210
| -4% | -$6.66K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $291K | Sell |
30,096
-15,395
| -34% | -$149K | ﹤0.01% | 2222 |
|
|
2021
Q3 | $813K | Buy |
45,491
+19,885
| +78% | +$355K | ﹤0.01% | 1912 |
|
|
2021
Q2 | $625K | Sell |
25,606
-5,059
| -16% | -$123K | ﹤0.01% | 1665 |
|
|
2021
Q1 | $813K | Sell |
30,665
-1,700
| -5% | -$45.1K | ﹤0.01% | 1527 |
|
|
2020
Q4 | $246K | Buy |
32,365
+18,027
| +126% | +$137K | ﹤0.01% | 2210 |
|
|
2020
Q3 | $72K | Sell |
14,338
-28,101
| -66% | -$141K | ﹤0.01% | 2079 |
|
|
2020
Q2 | $254K | Buy |
42,439
+8,008
| +23% | +$47.9K | ﹤0.01% | 2281 |
|
|
2020
Q1 | $153K | Buy |
34,431
+17,422
| +102% | +$77.4K | ﹤0.01% | 2283 |
|
|
2019
Q4 | $162K | Sell |
17,009
-2,737
| -14% | -$26.1K | ﹤0.01% | 2272 |
|
|
2019
Q3 | $155K | Buy |
+19,746
| New | +$155K | ﹤0.01% | 2138 |
|
|
2019
Q2 | – | Sell |
-6,462
| Closed | -$117K | – | 2961 |
|
|
2019
Q1 | $117K | Buy |
+6,462
| New | +$117K | ﹤0.01% | 2585 |
|